Use of CLEC1B for the determination of cardiovascular and thrombotic risk

Details for Australian Patent Application No. 2008303866 (hide)

Owner Sanofi-Aventis

Inventors Wonerow, Peter; Herrmann, Matthias; Kozian, Detlef

Agent Watermark

Pub. Number AU-A-2008303866

PCT Pub. Number WO2009/040002

Priority 07291134.0 24.09.07 EP

Filing date 13 September 2008

Wipo publication date 2 April 2009

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

15 April 2010 PCT application entered the National Phase

  PCT publication WO2009/040002 Priority application(s): WO2009/040002

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008303867-Ligand binding domains of nuclear receptors in controllable form and methods involving the same

2008303861-Wheelset press